Thalassemia is an autosomal recessive disease causing haemolytic anaemia. The ideal treatment of these patients involves regular, 2-4 weekly blood transfusions. The major complications by this treatment are the transmission of transfusion acquired infections such as Hepatitis B virus infection, Hepatitis C virus infection, Human immunodeficiency virus infection, Syphilis, Malaria and transfusion acquired iron overload. | A study of prevalence of hepatitis-B and hepatitis-C infection in thalassemic patients in a tertiary care hospital Jamnagar Gujarat India
